Bruker Historical Financial Ratios
BRKR Stock | USD 50.82 2.10 3.97% |
Bruker is presently reporting on over 113 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0033, PTB Ratio of 14.38 or Free Cash Flow Yield of 0.0149 will help investors to properly organize and evaluate Bruker financial condition quickly.
Bruker |
About Bruker Financial Ratios Analysis
BrukerFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bruker investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bruker financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bruker history.
Bruker Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Bruker stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bruker sales, a figure that is much harder to manipulate than other Bruker multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Bruker dividend as a percentage of Bruker stock price. Bruker dividend yield is a measure of Bruker stock productivity, which can be interpreted as interest rate earned on an Bruker investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Research And Ddevelopement To Revenue
The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.Most ratios from Bruker's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Research And Ddevelopement To Revenue is relatively stable compared to the past year. As of 02/23/2025, Capex To Revenue is likely to grow to 0.05, while Free Cash Flow Yield is likely to drop 0.01.
2022 | 2023 | 2024 | 2025 (projected) | |
Dividend Yield | 0.002934 | 0.002733 | 0.003446 | 0.003274 |
Price To Sales Ratio | 4.01 | 3.63 | 2.59 | 5.09 |
Bruker fundamentals Correlations
Click cells to compare fundamentals
Bruker Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bruker fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 4.18 | 5.25 | 4.01 | 3.63 | 2.59 | 5.09 | |
Dividend Yield | 0.002963 | 0.001905 | 0.002934 | 0.002733 | 0.003446 | 0.003274 | |
Ptb Ratio | 8.51 | 11.71 | 9.02 | 7.81 | 8.98 | 14.38 | |
Free Cash Flow Yield | 0.0283 | 0.015 | 0.0141 | 0.0226 | 0.0153 | 0.0149 | |
Operating Cash Flow Per Share | 2.17 | 1.87 | 1.76 | 2.39 | 1.69 | 1.77 | |
Stock Based Compensation To Revenue | 0.00805 | 0.007114 | 0.0109 | 0.008096 | 0.007286 | 0.007651 | |
Capex To Depreciation | 0.97 | 1.22 | 1.03 | 1.35 | 0.93 | 0.61 | |
Pb Ratio | 8.51 | 11.71 | 9.02 | 7.81 | 8.98 | 14.38 | |
Free Cash Flow Per Share | 0.9 | 1.53 | 1.26 | 0.96 | 1.66 | 0.94 | |
Roic | 0.13 | 0.099 | 0.0779 | 0.11 | 0.0965 | 0.0566 | |
Inventory Turnover | 1.51 | 1.7 | 1.52 | 1.5 | 1.35 | 1.26 | |
Net Income Per Share | 1.27 | 1.03 | 1.83 | 2.0 | 2.92 | 0.76 | |
Payables Turnover | 7.78 | 8.2 | 6.87 | 7.16 | 6.44 | 7.41 | |
Research And Ddevelopement To Revenue | 0.0906 | 0.0996 | 0.0913 | 0.0932 | 0.0994 | 0.13 | |
Capex To Revenue | 0.0494 | 0.038 | 0.047 | 0.0361 | 0.0349 | 0.0468 | |
Pocfratio | 24.92 | 44.99 | 38.77 | 30.73 | 34.77 | 36.51 | |
Interest Coverage | 17.24 | 28.9 | 26.88 | 26.64 | (6.63) | (6.29) | |
Payout Ratio | 0.16 | 0.0873 | 0.1 | 0.0688 | 0.27 | 0.18 | |
Capex To Operating Cash Flow | 0.29 | 0.33 | 0.45 | 0.31 | 0.47 | 0.49 | |
Pfcf Ratio | 35.33 | 66.72 | 71.03 | 44.23 | 65.28 | 60.4 | |
Income Quality | 2.06 | 1.01 | 0.88 | 0.82 | 2.21 | 1.85 | |
Pe Ratio | 52.62 | 45.85 | 34.24 | 25.18 | 77.23 | 81.77 | |
Return On Tangible Assets | 0.11 | 0.091 | 0.0661 | 0.0963 | 0.13 | 0.12 | |
Earnings Yield | 0.019 | 0.0218 | 0.0292 | 0.0397 | 0.0129 | 0.0164 | |
Current Ratio | 2.43 | 2.63 | 2.32 | 1.8 | 2.07 | 2.44 | |
Receivables Turnover | 5.93 | 5.8 | 4.25 | 4.77 | 4.29 | 4.46 | |
Debt To Equity | 0.91 | 1.23 | 1.08 | 1.0 | 0.9 | 0.95 | |
Capex Per Share | 0.64 | 0.61 | 0.8 | 0.73 | 0.79 | 0.83 | |
Revenue Per Share | 12.96 | 15.97 | 17.03 | 20.25 | 22.59 | 23.72 | |
Debt To Assets | 0.16 | 0.31 | 0.29 | 0.37 | 0.34 | 0.32 | |
Days Sales Outstanding | 61.58 | 62.93 | 85.86 | 76.56 | 88.04 | 73.49 | |
Book Value Per Share | 6.36 | 7.17 | 7.62 | 9.65 | 8.69 | 9.12 | |
Ev To Sales | 4.28 | 5.36 | 4.24 | 3.93 | 4.52 | 5.21 | |
Days Of Inventory On Hand | 241.18 | 214.51 | 239.47 | 243.54 | 280.07 | 271.57 | |
Cash Per Share | 4.77 | 7.72 | 5.02 | 3.34 | 3.0 | 1.79 | |
Days Payables Outstanding | 46.89 | 44.53 | 53.16 | 50.98 | 58.63 | 51.65 |
Pair Trading with Bruker
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.Moving together with Bruker Stock
Moving against Bruker Stock
0.66 | DOMH | Dominari Holdings | PairCorr |
0.65 | VIGL | Vigil Neuroscience | PairCorr |
0.62 | VALN | Valneva SE ADR | PairCorr |
0.45 | EQ | Equillium | PairCorr |
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.